EMIS is a clinical software supplier to the UK healthcare market. The company was originally established to serve the GP market, where it has a dominant position with a market share of 56% of UK GP practices. It has expanded from this position to create a broad range of products serving the community, child and mental healthcare (CCMH) market, the acute sector, and community pharmacies (where it has c 37% share), as well specialist software and screening services for diabetic retinopathy. The company strategy is to provide connected healthcare solutions to facilitate patient-centric care.
In this video, CEO Andy Thorburn reviews the company’s H118 results and discusses performance at a divisional level. He outlines the work the company has undertaken to resolve customer support issues in the Primary Care business as well as to improve service execution across the group. He also discusses product development over the period and gives an update on progress made towards defining the group’s long-term strategy. Finally, he discusses the current trading environment and gives his views on the company’s short- and longer-term outlook.